NATALIE JONES: Open Payments
NPI 1376902171 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,656 in 210 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $524 · 2025 $4,656
Food & beverage: $4,656
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 26 | $991 |
| Biogen, Inc. | 11 | $326 |
| Celgene Corporation | 30 | $315 |
| ABBVIE INC. | 17 | $302 |
| Alexion Pharmaceuticals, Inc. | 9 | $267 |
| UCB, Inc. | 9 | $251 |
| Novartis Pharmaceuticals Corporation | 10 | $237 |
| EMD Serono, Inc. | 8 | $206 |
| ARGENX US, INC. | 9 | $190 |
| Teva Pharmaceuticals USA, Inc. | 8 | $156 |
Products named: BRIUMVI, ZEPOSIA, ULTOMIRIS, KESIMPTA, TYSABRI, VYVGART HYTRULO, AUSTEDO XR, VALTOCO.
Industry payments across NC — which companies pay providers there.
